UROGEN PHARMA LTD (URGN) Stock Earnings Estimates
NASDAQ:URGN • IL0011407140
20.1 USD
-0.11 (-0.54%)
At close: Feb 13, 2026
20.1 USD
0 (0%)
After Hours: 2/13/2026, 8:00:01 PM
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 64.36M 33.97% | 82.713M 28.52% | 90.398M 9.29% | 114.33M 26.47% | 240.84M 110.65% | 396.88M 64.79% | 526.91M 32.76% | 721.88M 37.00% | 947.68M 31.28% | 1.437B 51.63% | 1.565B 8.91% | 1.696B 8.37% | |
| EBITDA YoY % growth | -78.12M 14.59% | -64.734M 17.14% | -96.453M -49.00% | -119.489M -23.88% | -38.042M 68.16% | 36.621M 196.26% | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -79.04M 14.36% | -65.536M 17.09% | -96.782M -47.68% | -124.766M -28.91% | -34.959M 71.98% | 72.719M 308.01% | 261.1M 259.05% | 418.72M 60.37% | 621.67M 48.47% | 1.13B 81.77% | 1.229B 8.76% | 1.335B 8.62% | |
| Operating Margin | -122.81% | -79.23% | -107.06% | -109.13% | -14.52% | 18.32% | 49.55% | 58.00% | 65.60% | 78.64% | 78.53% | 78.71% | |
| EPS YoY % growth | -4.78 3.57% | -3.73 22.02% | -3.23 13.40% | -3.24 -0.24% | -1.20 63.05% | 0.77 164.29% | 3.00 290.45% | 4.74 57.81% | 6.35 33.99% | 9.09 43.21% | 9.34 2.75% | 9.83 5.24% |
All data in USD
| Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.51 36.41% | -0.53 42.66% | -0.39 62.95% | -0.22 68.32% | -0.05 90.64% |
| Revenue Q2Q % growth | 40.938M 66.65% | 44.531M 119.86% | 54.321M 124.33% | 65.163M 137.11% | 73.969M 80.69% |
| EBITDA Q2Q % growth | -11.863M 56.59% | -19.064M 48.26% | -16.534M 59.96% | -5.042M 81.43% | N/A |
| EBIT Q2Q % growth | -16.857M 39.05% | -15.856M 57.05% | -10.035M 75.79% | -3.007M 89.02% | 3.171M 118.81% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2025 Q2Q % growth | -0.69 -25.45% | -0.71 | 0.02 | 2.31% |
| Q2 2025 Q2Q % growth | -1.05 -15.38% | -0.85 | -0.20 | -23.47% |
| Q1 2025 Q2Q % growth | -0.92 5.15% | -0.82 | -0.10 | -12.75% |
| Q4 2024 Q2Q % growth | -0.80 -11.11% | -0.73 | -0.07 | -8.93% |
| Q3 2024 Q2Q % growth | -0.55 19.12% | -0.83 | 0.28 | 34.01% |
| Q2 2024 Q2Q % growth | -0.91 11.65% | -0.85 | -0.06 | -7.23% |
| Q1 2024 Q2Q % growth | -0.97 25.38% | -0.88 | -0.09 | -9.81% |
| Q4 2023 Q2Q % growth | -0.72 40.98% | -0.69 | -0.03 | -3.81% |
| Q3 2023 Q2Q % growth | -0.68 39.98% | -0.86 | 0.18 | 21.20% |
| Q2 2023 Q2Q % growth | -1.03 12.71% | -1.16 | 0.13 | 11.11% |
| Q1 2023 Q2Q % growth | -1.30 -4.00% | -1.36 | 0.06 | 4.17% |
| Q4 2022 Q2Q % growth | -1.22 3.94% | -1.09 | -0.13 | -11.44% |
| Q3 2022 Q2Q % growth | -1.13 16.07% | -1.18 | 0.05 | 3.97% |
| Q2 2022 Q2Q % growth | -1.18 -0.85% | -1.30 | 0.12 | 9.27% |
| Q1 2022 Q2Q % growth | -1.25 -6.84% | -1.36 | 0.11 | 8.09% |
| Q4 2021 Q2Q % growth | -1.27 7.97% | -1.20 | -0.07 | -5.97% |
| Q3 2021 Q2Q % growth | -1.35 -3.05% | -1.32 | -0.03 | -2.47% |
| Q2 2021 Q2Q % growth | -1.17 18.75% | -1.15 | -0.02 | -1.87% |
| Q1 2021 Q2Q % growth | -1.17 34.64% | -1.32 | 0.15 | 11.42% |
| Q4 2020 Q2Q % growth | -1.38 | -1.40 | 0.02 | 1.34% |
| Q3 2020 Q2Q % growth | -1.31 | -1.52 | 0.21 | 14.09% |
| Q2 2020 Q2Q % growth | -1.44 | -1.61 | 0.17 | 10.77% |
| Q1 2020 Q2Q % growth | -1.79 | -1.65 | -0.14 | -8.62% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2025 Q2Q % growth | 27.482M 9.04% | 33.755M | -6.273M | -18.58% |
| Q2 2025 Q2Q % growth | 24.215M 10.83% | 23.598M | 617K | 2.61% |
| Q1 2025 Q2Q % growth | 20.254M 7.84% | 23.26M | -3.006M | -12.92% |
| Q4 2024 Q2Q % growth | 24.565M 4.40% | 26.147M | -1.582M | -6.05% |
| Q3 2024 Q2Q % growth | 25.204M 20.87% | 24.688M | 516K | 2.09% |
| Q2 2024 Q2Q % growth | 21.848M 3.35% | 24.442M | -2.594M | -10.61% |
| Q1 2024 Q2Q % growth | 18.781M 9.24% | 21.809M | -3.028M | -13.88% |
| Q4 2023 Q2Q % growth | 23.53M 30.07% | 23.02M | 510K | 2.22% |
| Q3 2023 Q2Q % growth | 20.852M 29.52% | 20.43M | 422K | 2.07% |
| Q2 2023 Q2Q % growth | 21.139M 27.34% | 20.523M | 616K | 3.00% |
| Q1 2023 Q2Q % growth | 17.192M 26.78% | 17.525M | -333K | -1.90% |
| Q4 2022 Q2Q % growth | 18.09M 11.87% | 18.882M | -792K | -4.19% |
| Q3 2022 Q2Q % growth | 16.1M 41.85% | 20.549M | -4.449M | -21.65% |
| Q2 2022 Q2Q % growth | 16.6M 27.40% | 17.576M | -976K | -5.55% |
| Q1 2022 Q2Q % growth | 13.56M 81.04% | 15.482M | -1.922M | -12.41% |
| Q4 2021 Q2Q % growth | 16.17M 102.89% | 16.822M | -652K | -3.88% |
| Q3 2021 Q2Q % growth | 11.35M 228.03% | 15.728M | -4.378M | -27.84% |
| Q2 2021 Q2Q % growth | 13.03M 3,421.62% | 11.955M | 1.075M | 8.99% |
| Q1 2021 Q2Q % growth | 7.49M | 9.234M | -1.744M | -18.89% |
| Q4 2020 Q2Q % growth | 7.97M | 7.72M | 250K | 3.24% |
| Q3 2020 Q2Q % growth | 3.46M | 3.405M | 55K | 1.62% |
| Q2 2020 Q2Q % growth | 370K | 264.517K | 105.483K | 39.88% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -3.37% | -10.53% | -0.63% | 0.1% |
| Revenue | -3.17% | -6.58% | -1.16% | -6.36% |